Quality Assessment of Anticoagulation Dose Management: Comparative Evaluation of Measures of Time-in-Therapeutic Range
Authors:
- 1 June 2003
- journal article
- research article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 15 (3) , 213-216
Abstract
Background: The results of clinical trials often hinge on the quality of oral anticoagulation management, yet the quality of such management is frequently not mentioned or measured. Time-in-therapeutic range (TTR) is one measure of quality of anticoagulation dose management, but various methodologies exist for measuring TTR. Objective: This study was initiated to compare three commonly used methodologies for measuring TTR to see how they compare within the same cohort of patients. Patients/Methods: Three common methodologies of calculating time-in-therapeutic range were analyzed retrospectively in a cohort of patients over six two-month intervals. Additional analysis was performed for three and six-month intervals. The methodologies included fraction of INRs in range; cross-section of the files; and linear interpolation. Results: Fraction of the INRs in range and cross-section of the files methodologies gave similar results, while linear interpolation yielded significantly shorter time-in-range for the two-month, three-month, and six-month intervals measured. The advantages and disadvantages of each methodology are discussed. Conclusions: The decision of which method to use should be based on clinic size, information desired, and clinic resources for ease of applying either of the methods in clinical practice. Each of these methodologies has their limitations and the question remains as to which method best reflects the quality of anticoagulation management. Regardless of these limitations, investigators are urged to employ at least one method of measuring the quality of oral anticoagulation management so as to better assess the validity of the clinical outcomes.Keywords
This publication has 20 references indexed in Scilit:
- Therapeutic quality control of oral anticoagulant therapy comparing the short‐acting acenocoumarol and the long‐acting phenprocoumonBritish Journal of Haematology, 2002
- Consensus Needed for Evaluating Safe and Adequate Anticoagulant ControlArchives of internal medicine (1960), 2001
- Managing Oral Anticoagulant TherapyChest, 2001
- Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists.1999
- Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart ValvesNew England Journal of Medicine, 1995
- Optimal Oral Anticoagulant Therapy in Patients with Nonrheumatic Atrial Fibrillation and Recent Cerebral IschemiaNew England Journal of Medicine, 1995
- Assessment of Therapeutic Quality Control in a Long-Term Anticoagulant Trial in Post-Myocardial Infarction PatientsThrombosis and Haemostasis, 1994
- A Method to Determine the Optimal Intensity of Oral Anticoagulant TherapyThrombosis and Haemostasis, 1993
- Recommended method for reporting therapeutic control of oral anticoagulant therapy. Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.1990
- Therapeutic Control of Oral Anticoagulant Treatment in the NetherlandsAmerican Journal of Clinical Pathology, 1988